Alteration on the expression of IL-1, PDGF, TGF-β, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients

Previously, we reported a deficient cloning capacity of the bone marrow (BM) mesenchymal stem cells to give colony-forming unit fibroblast (CFU-F) and an inefficient confluence capacity of BM stromal cells in advanced untreated lung cancer patients (LCP) and breast cancer patients (BCP). Moreover, a...

Descripción completa

Detalles Bibliográficos
Publicado: 2005
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_15473287_v14_n5_p587_Hofer
http://hdl.handle.net/20.500.12110/paper_15473287_v14_n5_p587_Hofer
Aporte de:
id paper:paper_15473287_v14_n5_p587_Hofer
record_format dspace
spelling paper:paper_15473287_v14_n5_p587_Hofer2023-06-08T16:21:16Z Alteration on the expression of IL-1, PDGF, TGF-β, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients cytokeratin 20 cytokeratin 7 epidermal growth factor receptor epithelial membrane antigen fibroblast growth factor receptor interleukin 1 receptor monoclonal antibody Myc protein oncoprotein platelet derived growth factor receptor polyclonal antibody protein c fos transforming growth factor beta receptor article bone marrow cell bone marrow metastasis breast carcinoma cancer infiltration cell proliferation colony forming unit F controlled study fibroblast human human cell human tissue immunocytochemistry lung non small cell cancer mesenchymal stem cell priority journal prognosis protein expression stroma cell Animals Bone Marrow Cells Breast Neoplasms Cells, Cultured Culture Media, Conditioned Female Fibroblasts Humans Lung Neoplasms Proto-Oncogene Proteins c-fos Proto-Oncogene Proteins c-myc Receptor, Epidermal Growth Factor Receptors, Fibroblast Growth Factor Receptors, Interleukin-1 Receptors, Platelet-Derived Growth Factor Receptors, Transforming Growth Factor beta Stromal Cells Tumor Stem Cell Assay Previously, we reported a deficient cloning capacity of the bone marrow (BM) mesenchymal stem cells to give colony-forming unit fibroblast (CFU-F) and an inefficient confluence capacity of BM stromal cells in advanced untreated lung cancer patients (LCP) and breast cancer patients (BCP). Moreover, a decreased level of bFGF at day 7 in the conditioned media from BM CFU-F cultures was found in both cancer groups when compared to the normal range. The current study was specially undertaken, to evaluate the percentage of subconfluent fibroblasts expressing receptors (R) of interleukin-1 (IL-1), platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), transforming growth factor (TGF-β), epidermal growth factor (EGF), and the proteins c-Fos and c-Myc in BM primary cultures from untreated LCP and BCP. An immunocytochemical study on subconfluent BM fibroblast cultures from 13 healthy patients, 16 LCP, and 8 BCP was performed, using as primary antibodies, anti-type I of IL-1 R (IL-1R-1), anti-α, β chains of PDGF R (PDGFR-α, PDGFR-β), anti-type I of FGF R (FGFR-I), anti-type I, II, and III of TGF-β R (TGF-βR-I, TGF-βR-II, and TGF-βR-III), anti-EGF R, anti-c-Fos, and anti-c-Myc. A diminished percentage of subconfluent fibroblasts expressing PDGFR-α, TGFβR-I, II, III, EGFR, and FGFR-I was found in LCP and BCP compared to healthy patients. A diminished percentage of subconfluent fibroblasts expressing c-Fos and c-Myc was found in patients when compared to healthy patients. The alterations we describe could help to explain the deficiency regarding the proliferative and confluence capacity of BM stroma cells in cancer patients. © Mary Ann Liebert. Inc. 2005 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_15473287_v14_n5_p587_Hofer http://hdl.handle.net/20.500.12110/paper_15473287_v14_n5_p587_Hofer
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic cytokeratin 20
cytokeratin 7
epidermal growth factor receptor
epithelial membrane antigen
fibroblast growth factor receptor
interleukin 1 receptor
monoclonal antibody
Myc protein
oncoprotein
platelet derived growth factor receptor
polyclonal antibody
protein c fos
transforming growth factor beta receptor
article
bone marrow cell
bone marrow metastasis
breast carcinoma
cancer infiltration
cell proliferation
colony forming unit F
controlled study
fibroblast
human
human cell
human tissue
immunocytochemistry
lung non small cell cancer
mesenchymal stem cell
priority journal
prognosis
protein expression
stroma cell
Animals
Bone Marrow Cells
Breast Neoplasms
Cells, Cultured
Culture Media, Conditioned
Female
Fibroblasts
Humans
Lung Neoplasms
Proto-Oncogene Proteins c-fos
Proto-Oncogene Proteins c-myc
Receptor, Epidermal Growth Factor
Receptors, Fibroblast Growth Factor
Receptors, Interleukin-1
Receptors, Platelet-Derived Growth Factor
Receptors, Transforming Growth Factor beta
Stromal Cells
Tumor Stem Cell Assay
spellingShingle cytokeratin 20
cytokeratin 7
epidermal growth factor receptor
epithelial membrane antigen
fibroblast growth factor receptor
interleukin 1 receptor
monoclonal antibody
Myc protein
oncoprotein
platelet derived growth factor receptor
polyclonal antibody
protein c fos
transforming growth factor beta receptor
article
bone marrow cell
bone marrow metastasis
breast carcinoma
cancer infiltration
cell proliferation
colony forming unit F
controlled study
fibroblast
human
human cell
human tissue
immunocytochemistry
lung non small cell cancer
mesenchymal stem cell
priority journal
prognosis
protein expression
stroma cell
Animals
Bone Marrow Cells
Breast Neoplasms
Cells, Cultured
Culture Media, Conditioned
Female
Fibroblasts
Humans
Lung Neoplasms
Proto-Oncogene Proteins c-fos
Proto-Oncogene Proteins c-myc
Receptor, Epidermal Growth Factor
Receptors, Fibroblast Growth Factor
Receptors, Interleukin-1
Receptors, Platelet-Derived Growth Factor
Receptors, Transforming Growth Factor beta
Stromal Cells
Tumor Stem Cell Assay
Alteration on the expression of IL-1, PDGF, TGF-β, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients
topic_facet cytokeratin 20
cytokeratin 7
epidermal growth factor receptor
epithelial membrane antigen
fibroblast growth factor receptor
interleukin 1 receptor
monoclonal antibody
Myc protein
oncoprotein
platelet derived growth factor receptor
polyclonal antibody
protein c fos
transforming growth factor beta receptor
article
bone marrow cell
bone marrow metastasis
breast carcinoma
cancer infiltration
cell proliferation
colony forming unit F
controlled study
fibroblast
human
human cell
human tissue
immunocytochemistry
lung non small cell cancer
mesenchymal stem cell
priority journal
prognosis
protein expression
stroma cell
Animals
Bone Marrow Cells
Breast Neoplasms
Cells, Cultured
Culture Media, Conditioned
Female
Fibroblasts
Humans
Lung Neoplasms
Proto-Oncogene Proteins c-fos
Proto-Oncogene Proteins c-myc
Receptor, Epidermal Growth Factor
Receptors, Fibroblast Growth Factor
Receptors, Interleukin-1
Receptors, Platelet-Derived Growth Factor
Receptors, Transforming Growth Factor beta
Stromal Cells
Tumor Stem Cell Assay
description Previously, we reported a deficient cloning capacity of the bone marrow (BM) mesenchymal stem cells to give colony-forming unit fibroblast (CFU-F) and an inefficient confluence capacity of BM stromal cells in advanced untreated lung cancer patients (LCP) and breast cancer patients (BCP). Moreover, a decreased level of bFGF at day 7 in the conditioned media from BM CFU-F cultures was found in both cancer groups when compared to the normal range. The current study was specially undertaken, to evaluate the percentage of subconfluent fibroblasts expressing receptors (R) of interleukin-1 (IL-1), platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), transforming growth factor (TGF-β), epidermal growth factor (EGF), and the proteins c-Fos and c-Myc in BM primary cultures from untreated LCP and BCP. An immunocytochemical study on subconfluent BM fibroblast cultures from 13 healthy patients, 16 LCP, and 8 BCP was performed, using as primary antibodies, anti-type I of IL-1 R (IL-1R-1), anti-α, β chains of PDGF R (PDGFR-α, PDGFR-β), anti-type I of FGF R (FGFR-I), anti-type I, II, and III of TGF-β R (TGF-βR-I, TGF-βR-II, and TGF-βR-III), anti-EGF R, anti-c-Fos, and anti-c-Myc. A diminished percentage of subconfluent fibroblasts expressing PDGFR-α, TGFβR-I, II, III, EGFR, and FGFR-I was found in LCP and BCP compared to healthy patients. A diminished percentage of subconfluent fibroblasts expressing c-Fos and c-Myc was found in patients when compared to healthy patients. The alterations we describe could help to explain the deficiency regarding the proliferative and confluence capacity of BM stroma cells in cancer patients. © Mary Ann Liebert. Inc.
title Alteration on the expression of IL-1, PDGF, TGF-β, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients
title_short Alteration on the expression of IL-1, PDGF, TGF-β, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients
title_full Alteration on the expression of IL-1, PDGF, TGF-β, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients
title_fullStr Alteration on the expression of IL-1, PDGF, TGF-β, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients
title_full_unstemmed Alteration on the expression of IL-1, PDGF, TGF-β, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients
title_sort alteration on the expression of il-1, pdgf, tgf-β, egf, and fgf receptors and c-fos and c-myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients
publishDate 2005
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_15473287_v14_n5_p587_Hofer
http://hdl.handle.net/20.500.12110/paper_15473287_v14_n5_p587_Hofer
_version_ 1768543721857482752